Precision Vibration Therapy for Older Adults and Stroke Survivors
Tests a vibration device for muscle strength and movement in older adults and stroke survivors.
Plain-language title generated from the registry record
Registry title: Precision Vibration Therapy for Neuromuscular and Functional Improvement in Older Adults and Stroke Survivors
Key facts
- Where
- Taipei, TaiwanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 95 years old?
Source: NCT07351877, who can take part
Where in Taiwan
- National Center for Geriatrics and Welfare Research, National Health Research InstitutesTaipei, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Health Research Institutes, Taiwan
- Trial code
- NCT07351877
- Record updated
- 20 January 2026
- Original description
To address muscle weakness, sensory degradation, functional decline, and pain caused by geriatric syndromes in older adults and stroke survivors, this project proposes a series of studies aimed at improving neuromuscular performance, muscle strength, proprioceptive gain, functional outcomes, and pain relief through the use of a precise vibration system.Read full original descriptionShow less
Exploring the Clinical Benefits of Precision Vibration on Neuromuscular Induction, Proprioceptive Gain, Functional Enhancement, and Pain Relief in Older Adults and and Stroke Survivors
To address muscle weakness, sensory degradation, functional decline, and pain caused by geriatric syndromes in older adults and stroke survivors, this project proposes a series of studies aimed at improving neuromuscular performance, muscle strength, proprioceptive gain, functional outcomes, and pain relief through the use of a precise vibration system.
In the first phase, a vibration exercise system will be implemented to recruit frail older adults and older adults with stroke for clinical trials. The goal is to verify the benefits of vibration intervention on limb muscle strength, proprioception, and movement function.
In the third phase, quantitative pain assessments and related scales will be used to evaluate chronic pain thresholds and affected regions in older adults and stroke survivors, and to validate the effectiveness of vibration intervention in alleviating their pain.
Inclusion: Older Adults:; Meet two or more criteria of the Study of Osteoporotic Fractures (SOF) frailty index; Willing to participate in the study and comply with all study procedures; Able to wear and safely use the vibration device; Normal cognitive function (Mini-Mental State Examination [MMSE] score ≥ 23); Presence of knee joint pain in the lower limbs; Stroke Survivors:; Clinical diagnosis of ischemic or hemorrhagic stroke confirmed by a physician; Clinically stable stroke condition (i.e., not in an acute or unstable phase); Brunnstrom stage ≥ III for the affected limb; Cognitive ability sufficient to follow study procedures (MMSE score ≥ 23); Modified Ashworth Scale (MAS) score < 3 for the paretic limb; Able to sit safely and participate in vibration or rehabilitation sessions for up to 60 minutes per visit; Willing and able to comply with all study procedures and provide written informed consent.
Exclusion: Concomitant vestibular or cerebellar disorders that severely impair motor performance; History of surgery on the upper or lower limbs within the past 6 months; Stroke Survivors:; Recurrent stroke during the current episode (i.e., acute re-stroke) or otherwise clinically unstable stroke presentation; Cognitive impairment attributable to stroke that precludes effective communication or adherence to the study protocol; Other neurological or psychiatric disorders judged likely to interfere with motor performance or study outcomes; Older Adults:; Acute or chronic neurological injury involving the upper or lower limbs within the past 6 months; Acute or chronic musculoskeletal injury involving the upper or lower limbs within the past 6 months; Markedly elevated spasticity preventing isolated voluntary movement of the target limb (MAS score ≥ 3); Hemianopsia or severe hemineglect that significantly interferes with task execution; Orthopedic or traumatic comorbidities causing significant pain or limiting safe participation during evaluation or intervention.